Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI
SUZHOU, China, May 12, 2026 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd. (“Ribo”, 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Medicine (“Insilico”, 03696.HK). Both parties
